Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares MSCI Japan ETF
EWJ
$21.9B
| $53M | 0.03% |
784,959
+15,367
| +2% | +$1.05M |
|
202
Integer Holdings
ITGR
$4.12B
| $53M | 0.03% |
562,603
-79,996
| -12% | -$7.37M |
|
203
ATI
ATI
$25.6B
| $52.5M | 0.03% |
2,518,129
-136,909
| -5% | -$3.14M |
|
|
NUVA
204
DELISTED
NuVasive, Inc.
NUVA
| $52.4M | 0.03% |
772,763
-112,338
| -13% | -$7.67M |
|
205
Qualcomm
QCOM
$155B
| $52.1M | 0.03% |
364,670
+24,777
| +7% | +$3.35M |
|
206
Medpace
MEDP
$16.1B
| $51.8M | 0.03% |
293,024
-728
| -0.2% | -$126K |
|
|
MZTI
207
The Marzetti Company
MZTI
$2.93B
| $50.8M | 0.03% |
262,605
-21,367
| -8% | -$4.01M |
|
208
Knowles
KN
$3.13B
| $50.5M | 0.03% |
2,559,751
-89,026
| -3% | -$1.81M |
|
209
NETSCOUT
NTCT
$2.96B
| $50.5M | 0.03% |
1,768,437
-91,975
| -5% | -$2.61M |
|
210
iShares US Financials ETF
IYF
$4.67B
| $48.9M | 0.03% |
603,661
+58,270
| +11% | +$4.68M |
|
|
JHG
211
DELISTED
Janus Henderson
JHG
| $48.7M | 0.03% |
1,255,820
-92,882
| -7% | -$3.38M |
|
|
212
iShares MBS ETF
MBB
$38.9B
| $48.7M | 0.03% |
449,850
-410,056
| -48% | -$44.5M |
|
213
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.22B
| $46.3M | 0.03% |
1,024,460
+61,731
| +6% | +$2.86M |
|
214
iShares US Medical Devices ETF
IHI
$3.13B
| $45.9M | 0.03% |
763,326
+59,238
| +8% | +$3.43M |
|
215
Diageo
DEO
$49B
| $45.9M | 0.03% |
239,558
-1,505
| -0.6% | -$280K |
|
|
UMPQ
216
DELISTED
Umpqua Holdings Corp
UMPQ
| $45.5M | 0.03% |
2,466,859
-111,926
| -4% | -$2.08M |
|
217
Plexus
PLXS
$6.72B
| $45.4M | 0.03% |
496,248
-21,947
| -4% | -$2.06M |
|
218
Wintrust Financial
WTFC
$10.8B
| $44.4M | 0.03% |
587,340
-22,943
| -4% | -$1.79M |
|
219
CONMED
CNMD
$1.39B
| $44.2M | 0.03% |
321,818
+12,569
| +4% | +$1.72M |
|
220
Integra LifeSciences
IART
$1.29B
| $43.3M | 0.03% |
634,172
-10,010
| -2% | -$708K |
|
221
Deere & Co
DE
$160B
| $42.9M | 0.03% |
121,565
+7
| +0% | +$2.56K |
|
222
Range Resources
RRC
$9.38B
| $42.5M | 0.03% |
2,533,550
-179,754
| -7% | -$2.26M |
|
223
Sally Beauty Holdings
SBH
$1.43B
| $42.1M | 0.03% |
1,906,110
-118,254
| -6% | -$2.49M |
|
224
Halozyme
HALO
$9.79B
| $41.9M | 0.03% |
923,714
+25,637
| +3% | +$1.13M |
|
225
Nice
NICE
$5.79B
| $41.6M | 0.03% |
168,084
-2,205
| -1% | -$508K |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.